Key PointseIF4E/XPO1 collaboratively transport GATA-3 and GATA-3 targets and are thus therapeutic vulnerabilities in GATA-3–driven TCLs.Impaired eIF4E/XPO1
Findings from RedirecTT-1 show responses across different dose levels of talquetamab/teclistamab among those with multiple myeloma.
Health Affairs’ Jeff Byers welcomes Kinika Young of The Leukemia & Lymphoma Society to the program to discuss a recent final rule/advisory issued by the…
PHILADELPHIA (January 31, 2025) — Eric Goodlev, MD, an Associate Professor in the Supportive Oncology and Palliative Care Program at Fox Chase Cancer Center, was recently named…
Linde Morsink, MD, this year’s recipient of the Editorial Award for Clinical Research, previews her lecture on using post transplantation cyclophosphamide (PTCy) in combination with…
Polatuzumab vedotin plus R-CHP improved PFS and DFS vs R-CHOP at 5 years in previously untreated patients with diffuse large B-cell lymphoma.
A bipartisan group of senators reintroduced the Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act, which would expand Medicare coverage to include certain FDA-approved MCED…
Authors: Bhaavna Yalavarthi1 and Grace Collins2 In 2011, Friends published a study in Health Affairs that challenged the prevailing narrative of the time, which suggested…
9th Annual Blood Cover Art Contest is now open. In recognition of authors who published in Blood and images used in advancement of science, we…
This report on nutrition among patients with cancer highlights current and potential roles for oncology nurses in incorporating nutrition care into cancer care.
This booklet discusses the various impacts that amyloidosis may have on a patient’s nerves and potential management techniques.
